Cytokinetics gets jump on BMS as Myqorzo succeeds in non-obstructive HCM trial - FirstWord Pharma

Cytokinetics gets jump on BMS as Myqorzo succeeds in non-obstructive HCM trial  FirstWord Pharma

BMS, SLS Golf Compete in Four-Way - WRBI Radio

BMS, SLS Golf Compete in Four-Way  WRBI Radio

Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026 - Bristol ...

Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026  Bristol Myers Squibb

BMS calls time on Zymeworks collab, ending work on bispecific - Fierce Biotech

BMS calls time on Zymeworks collab, ending work on bispecific  Fierce Biotech

BMS.JPEG - The Mountaineer

BMS.JPEG  The Mountaineer

Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger - Fierce ...

Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger  Fierce Pharma

BMS brings the buzz around late-stage readouts amid a so-so Q1 - pharmaceutical-technology.com

BMS brings the buzz around late-stage readouts amid a so-so Q1  pharmaceutical-technology.com

BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout - BioSpace

BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout  BioSpace

Motor officers from 6 states at BMS for competition to benefit Speedway Children’s Charities - WJHL

Motor officers from 6 states at BMS for competition to benefit Speedway Children’s Charities  WJHL

Cybersecurity built-in: LONGi BMS now IEC 62443-4-2 certified - Energy-Storage.News

Cybersecurity built-in: LONGi BMS now IEC 62443-4-2 certified  Energy-Storage.News

Strouse to leave BMS for statewide role - Greensburg Daily News

Strouse to leave BMS for statewide role  Greensburg Daily News

Strouse to Leave BMS for Statewide Role - Eagle Country 99.3

Strouse to Leave BMS for Statewide Role  Eagle Country 99.3

MaxVolt Energy Unveils IoT-Enabled Smart BMS for Lithium Batteries - Energetica India Magazine

MaxVolt Energy Unveils IoT-Enabled Smart BMS for Lithium Batteries  Energetica India Magazine

BMS: The 2nd Annual Schizophrenia Awareness Month kicks off in Wellsville on Saturday May 2 - the...

BMS: The 2nd Annual Schizophrenia Awareness Month kicks off in Wellsville on Saturday May 2  the wellsville sun

Earnings call transcript: Bristol Myers Squibb Q1 2026 earnings beat expectations - Investing.com

Earnings call transcript: Bristol Myers Squibb Q1 2026 earnings beat expectations  Investing.com

CRC approval for BMS's Krazati in doubt after confirmatory study miss - FirstWord Pharma

CRC approval for BMS's Krazati in doubt after confirmatory study miss  FirstWord Pharma

BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfol...

BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio  Fierce Pharma

BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut - BioSpace

BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut  BioSpace

Eliquis resilience drives first-quarter sales beat for BMS - FirstWord Pharma

Eliquis resilience drives first-quarter sales beat for BMS  FirstWord Pharma

Law enforcement agencies compete in motorcycle training and skills competition at BMS - WCYB

Law enforcement agencies compete in motorcycle training and skills competition at BMS  WCYB

BMS beats estimates and reaffirms guidance - The Pharma Letter

BMS beats estimates and reaffirms guidance  The Pharma Letter

Champions in Care - Bristol Myers Squibb

Champions in Care  Bristol Myers Squibb

The Time Back campaign honors the most precious gift oncologists provide in cancer care: time - B...

The Time Back campaign honors the most precious gift oncologists provide in cancer care: time  Bristol Myers Squibb

Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS - Fierce B...

Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS  Fierce Biotech

Science Firsthand: Making the leap to intentionally designed degraders - Bristol Myers Squibb

Science Firsthand: Making the leap to intentionally designed degraders  Bristol Myers Squibb

Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb

Science Firsthand: Translating the promise of cell therapy  Bristol Myers Squibb

Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi - Bri...

Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi  Bristol Myers Squibb

BMS builds momentum for CELMoD drug after improving myeloma PFS in phase 3 - Fierce Biotech

BMS builds momentum for CELMoD drug after improving myeloma PFS in phase 3  Fierce Biotech

Biopharma bites: BMS axes more staff, Biogen's mAb deal, plus CAR-T data from Kyverna - FirstWord...

Biopharma bites: BMS axes more staff, Biogen's mAb deal, plus CAR-T data from Kyverna  FirstWord Pharma

Bristol Myers Squibb Logs Higher Sales, Profit - WSJ

Bristol Myers Squibb Logs Higher Sales, Profit  WSJ

Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™ - Messeng...

Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™  Messenger-Inquirer

Redefining biologics & cell therapy manufacturing at Devens - Bristol Myers Squibb

Redefining biologics & cell therapy manufacturing at Devens  Bristol Myers Squibb

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)  Bristol Myers Squibb

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY) - Seeking Alpha

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)  Seeking Alpha

BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments - BioSpace

BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments  BioSpace

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B  Fierce Biotech

JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff - Clinical Trials Arena

JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff  Clinical Trials Arena

Bristol Myers Squibb to cut 206 more jobs in New Jersey (updated) - NJBIZ

Bristol Myers Squibb to cut 206 more jobs in New Jersey (updated)  NJBIZ

Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program  Bristol Myers Squibb

Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis - Fie...

Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis  Fierce Biotech

Building a healthier future together: Strengthening cancer care across Africa through partnership...

Building a healthier future together: Strengthening cancer care across Africa through partnership  Bristol Myers Squibb

Honoring oncologists through the Time Back campaign - Bristol Myers Squibb

Honoring oncologists through the Time Back campaign  Bristol Myers Squibb

Why Bristol Myers Squibb Stock Rocked the Market Today - The Motley Fool

Why Bristol Myers Squibb Stock Rocked the Market Today  The Motley Fool

A bold blueprint for transforming lupus outcomes - Bristol Myers Squibb

A bold blueprint for transforming lupus outcomes  Bristol Myers Squibb

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line  BioSpace

Samsung SDI Plans Localization of ESS Battery Management Chips - thelec.net

Samsung SDI Plans Localization of ESS Battery Management Chips  thelec.net

Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countri...

Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countries  Bristol Myers Squibb

Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial - Fierce ...

Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial  Fierce Biotech

Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb

Nurse practitioners impact patient care and foster collaboration  Bristol Myers Squibb

Bhooth Bangla Box Office Day 19: Akshay Kumar Registers 122% BMS Jump In Only 3 Hours - Another 3...

Bhooth Bangla Box Office Day 19: Akshay Kumar Registers 122% BMS Jump In Only 3 Hours - Another 3rd Tuesday Turns Terrific!  Koimoi

BMS Beats Again Despite Eliquis and Cobenfy Disappointments - BioSpace

BMS Beats Again Despite Eliquis and Cobenfy Disappointments  BioSpace

Driving patient-centric care through global patient outreach - Bristol Myers Squibb

Driving patient-centric care through global patient outreach  Bristol Myers Squibb

With declining sales of legacy meds, BMS leans on new growth drivers to weather the storm - Fierc...

With declining sales of legacy meds, BMS leans on new growth drivers to weather the storm  Fierce Pharma

BMS snags top neuro researcher from Eisai—Chutes & Ladders - Fierce Biotech

BMS snags top neuro researcher from Eisai—Chutes & Ladders  Fierce Biotech

BMS pens $850M solid tumor pact with T-cell engager biotech Janux - Fierce Biotech

BMS pens $850M solid tumor pact with T-cell engager biotech Janux  Fierce Biotech

Bristol Myers Squibb Reports First Quarter Financial Results for 2026 - The AI Journal

Bristol Myers Squibb Reports First Quarter Financial Results for 2026  The AI Journal

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients  Bain Capital

Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking ...

Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it?  Bristol Myers Squibb

Biopharma bites: Layoffs at BMS, Generate's IPO plans, Fortress's voucher sale…and more - FirstWo...

Biopharma bites: Layoffs at BMS, Generate's IPO plans, Fortress's voucher sale…and more  FirstWord Pharma

BMS' Cobenfy TV ad is latest target of FDA untitled letter spree - Fierce Pharma

BMS' Cobenfy TV ad is latest target of FDA untitled letter spree  Fierce Pharma

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA - Fierc...

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA  Fierce Biotech

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover  BioSpace

Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb

Science Firsthand: The renaissance of neuroscience R&D  Bristol Myers Squibb

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients  Fierce Pharma

"Too many patients in rural America face barriers to cardiovascular care — barriers that - Bristo...

"Too many patients in rural America face barriers to cardiovascular care — barriers that  Bristol Myers Squibb

Crystallizing exponential possibilities in protein degradation - Bristol Myers Squibb

Crystallizing exponential possibilities in protein degradation  Bristol Myers Squibb

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis  Fierce Pharma

Water stewardship for environmental sustainability - Bristol Myers Squibb

Water stewardship for environmental sustainability  Bristol Myers Squibb

Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma

Merck & Co., BMS to lay off over 300 staffers in New Jersey  FirstWord Pharma

JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy - BioSpace

JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy  BioSpace

Harnessing the Potential of Anti-Cancer Modalities - Bristol Myers Squibb

Harnessing the Potential of Anti-Cancer Modalities  Bristol Myers Squibb

New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role - Purd...

New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role  Purdue University College of Veterinary Medicine

Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review - Ad Age

Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review  Ad Age

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future  Fierce Biotech

Bristol Myers Squibb honoured with the prestigious Prix Galien Award - Bristol Myers Squibb

Bristol Myers Squibb honoured with the prestigious Prix Galien Award  Bristol Myers Squibb

BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe - JUVE Patent

BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe  JUVE Patent

A global journey through BMS’ R&D hubs - Bristol Myers Squibb

A global journey through BMS’ R&D hubs  Bristol Myers Squibb

BMS sells controlling stake in historic US-China pharmaceutical joint venture - Fierce Pharma

BMS sells controlling stake in historic US-China pharmaceutical joint venture  Fierce Pharma

Veterans redefining manufacturing leadership in pharma - Bristol Myers Squibb

Veterans redefining manufacturing leadership in pharma  Bristol Myers Squibb

How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - Harvard Business Review

How Bristol Myers Squibb Transformed Working Capital to Fund Its Future  Harvard Business Review

New RayzeBio hub accelerates next-gen cancer therapies - Bristol Myers Squibb

New RayzeBio hub accelerates next-gen cancer therapies  Bristol Myers Squibb

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia  Fierce Biotech

Karen Costello appointed General Manager of Bristol Myers Squibb Benelux - Bristol Myers Squibb

Karen Costello appointed General Manager of Bristol Myers Squibb Benelux  Bristol Myers Squibb

Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal - Fierce Pharma

Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal  Fierce Pharma

BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes - Fierce Biotech

BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes  Fierce Biotech

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial  Fierce Biotech

Human connections driving innovation & impact at GPS - Bristol Myers Squibb

Human connections driving innovation & impact at GPS  Bristol Myers Squibb

Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva

Bristol Myers Squibb Commits to Veeva Vault CRM  Veeva

Chris Shibutani, MD - Bristol Myers Squibb

Chris Shibutani, MD  Bristol Myers Squibb

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study  BioSpace

BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates...

BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates  BioSpace

Workforce Planner: Manage people and projects in BMS - Kaseya

Workforce Planner: Manage people and projects in BMS  Kaseya

Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech

Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma  Fierce Biotech

Bhooth Bangla Box Office Update on Day 19: Akshay Kumar Sees 122% Increase in BMS Within Just 3 H...

Bhooth Bangla Box Office Update on Day 19: Akshay Kumar Sees 122% Increase in BMS Within Just 3 Hours – Marks Another Third Tuesday  zoomtventertainment.com

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence  Fierce Biotech

BMS Teacher of the Year arrested on child sex abuse charges - KATC

BMS Teacher of the Year arrested on child sex abuse charges  KATC

Protein degradation: Recycling in action - Bristol Myers Squibb

Protein degradation: Recycling in action  Bristol Myers Squibb

Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? - Labiotech.eu

Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff?  Labiotech.eu

Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless - BioSpace

Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless  BioSpace

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy  Fierce Pharma